COEP

Coeptis Therapeutics Holdings (COEP)

About Coeptis Therapeutics Holdings (COEP)

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Details

Daily high
$15.25
Daily low
$13.61
Price at open
--
52 Week High
$21.41
52 Week Low
$2.31
Market cap
77.1M
Dividend yield
0.00%
Volume
47
Avg. volume
99,435
P/E ratio
-3.65

Coeptis Therapeutics Holdings News

Details

Daily high
$15.25
Daily low
$13.61
Price at open
--
52 Week High
$21.41
52 Week Low
$2.31
Market cap
77.1M
Dividend yield
0.00%
Volume
47
Avg. volume
99,435
P/E ratio
-3.65